PharmaEssentia USA

PharmaEssentia USA is owned by PharmaEssentia.

PharmaEssentia is a company listed under the stock ticker 6446 (TW).

PharmaEssentia has a direct presence in 2 countries.

View the org chart displaying its 11 main executives

Most searched biographies at PharmaEssentia USA

• Meredith Manning, General Manager
• Jason Mitch, Vice President and Head of Market Access
• Roddy McIlwain, Senior Vice President, Head of Sales and Marketing

Popular executive movements at PharmaEssentia

• Robert Geller has joined the company as Head of Medical Affairs  (posted on April 25 2024).

Create your alert
to follow the executive moves at PharmaEssentia USA.

PharmaEssentia has 1,860 competitors including Pfizer (United States (USA)), Sanofi (France) and Johnson & Johnson (United States (USA)).

Popular M&A news in Pharmaceuticals

• MedMen has filed for bankruptcy protection  (posted on April 28 2024).
• AstraZeneca has announced the acquisition of Fusion Pharma  (posted on March 23 2024).
• AstraZeneca has announced the acquisition of Amolyt Pharma  (posted on March 19 2024).

Popular contacts in Pharmaceuticals

• Jean-Frédéric Paulsen - Executive Chairman of the Board at Ferring Pharmaceuticals
• Thierry Abribat - Chief Executive Officer at Amolyt Pharma
• Lucia Aleotti - Director at Menarini Group

Learn more about the Pharmaceuticals industry >

Press releases by PharmaEssentia USA

Social media about PharmaEssentia USA

• PharmaEssentia USA on Wikipedia, Google News & Yahoo Finance
• PharmaEssentia USA on LinkedIn, Twitter & YouTube

Contact by email its executives including Meredith Manning

Call PharmaEssentia USA at +1 617...

View the org chart

Register to receive your alert

Report an error